Allogeneic hematopoietic stem cell transplantation (HSCT) beyond first complete remission (CR) in patients with acute myeloid leukemia (AML): Results from the AMLCG1999 trial

Evers, G. and Beelen, D. W. and Braess, J. and Sauerland, M. C. and Kolb, H. J. and Reichle, A. and Holler, E. and Schwerdtfeger, R. and Arnold, R. and Scheid, C. and Krug, U. and Mueller-Tidow, C. and Schliemann, C. and Mikesch, J. -H. and Lenz, G. and Woermann, B. J. and Hiddemann, W. and Berdel, W. E. and Stelljes, M. (2018) Allogeneic hematopoietic stem cell transplantation (HSCT) beyond first complete remission (CR) in patients with acute myeloid leukemia (AML): Results from the AMLCG1999 trial. ONCOLOGY RESEARCH AND TREATMENT, 41 (suppl4). pp. 117-118. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 23 Jun 2020 14:13
Last Modified: 23 Jun 2020 14:13
URI: https://pred.uni-regensburg.de/id/eprint/15322

Actions (login required)

View Item View Item